LEADER 03836nam  2200949 a 450 
001 9910810897503321
005 20240410001143.0
010   $a0-19-770665-7
010   $a1-280-84585-6
010   $a9786610845859
010   $a0-19-974824-1
010   $a1-4294-5923-9
024 7 $a10.1093/oso/9780195187762.001.0001
035   $a(CKB)1000000000471467
035   $a(EBL)2012824
035   $a(OCoLC)923712716
035   $a(SSID)ssj0000153184
035   $a(PQKBManifestationID)11147421
035   $a(PQKBTitleCode)TC0000153184
035   $a(PQKBWorkID)10391781
035   $a(PQKB)11249681
035   $a(Au-PeEL)EBL2012824
035   $a(CaPaEBR)ebr10375120
035   $a(CaONFJC)MIL84585
035   $a(MiAaPQ)EBC2012824
035   $a(OCoLC)1406787374
035   $a(StDuBDS)9780197706657
035   $a(EXLCZ)991000000000471467
100   $a20051228e20232007  uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aFalse hope $ebone marrow transplantation for breast cancer /$fRichard A. Rettig [and others]$b[electronic resource]
205   $a1st ed.
210  1$aOxford :$cOxford University Press,$d2023.
215   $a1 online resource (368 p.)
225 1 $aOxford scholarship online
300   $aFormerly CIP.$5Uk
300   $aPreviously issued in print: 2007.
311   $a0-19-518776-8 
320   $aIncludes bibliographical references (p. 315-341) and index.
327   $aBreast cancer patients and the emergence of a treatment -- Jumping the gun -- Court trials -- Litigation strategies -- Entrepreneurial oncology -- Government mandates -- Technology assessments -- Clinical trials -- D?enouement -- Values in conflict.
330 8 $aIn the late 1990s, a promising new treatment for breast cancer emerged: high-dose chemotherapy with autologous bone marrow transplantation or HDC/ABMT. This text tells of the rise and demise of HDC/ABMT for metastatic and early stage breast cancer.
410  0$aOxford scholarship online.
606   $aBreast$xCancer$xChemotherapy$zUnited States$xHistory
606   $aBone marrow$xTransplantation$zUnited States$xHistory
606   $aAutotransplantation$zUnited States$xHistory
606   $aBreast$xCancer$xChemotherapy$xComplications
606   $aBone marrow$xTransplantation$xComplications
606   $aAutotransplantation$xComplications
606   $aBreast Neoplasms$xhistory$zUnited States
606   $aBreast Neoplasms$xtherapy$zUnited States
606   $aAntineoplastic Combined Chemotherapy Protocols$xhistory$zUnited States
606   $aBone Marrow Transplantation$xhistory$zUnited States
606   $aCombined Modality Therapy$xhistory$zUnited States
606   $aHistory, 20th Century$zUnited States
606   $aTransplantation, Autologous$xhistory$zUnited States
615  0$aBreast$xCancer$xChemotherapy$xHistory.
615  0$aBone marrow$xTransplantation$xHistory.
615  0$aAutotransplantation$xHistory.
615  0$aBreast$xCancer$xChemotherapy$xComplications.
615  0$aBone marrow$xTransplantation$xComplications.
615  0$aAutotransplantation$xComplications.
615 12$aBreast Neoplasms$xhistory
615 12$aBreast Neoplasms$xtherapy
615 22$aAntineoplastic Combined Chemotherapy Protocols$xhistory
615 22$aBone Marrow Transplantation$xhistory
615 22$aCombined Modality Therapy$xhistory
615 22$aHistory, 20th Century
615 22$aTransplantation, Autologous$xhistory
676   $a616.99/449061
700   $aRettig$b Richard A.$00
801  0$bStDuBDS
801  1$bStDuBDS
801  2$bUk
801  2$bStDuBDSZ
906   $aBOOK
912   $a9910810897503321
996   $aFalse hope$94075218
997   $aUNINA